# Mesenchymal Stem Cell Therapy in Multiple System Atrophy

> **NCT02315027** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Mayo Clinic** · enrollment: 30 (actual)

## Conditions studied

- MSA

## Interventions

- **BIOLOGICAL:** Autologous Mesenchymal Stem Cells
- **BIOLOGICAL:** Autologous Mesenchymal Stem Cells
- **BIOLOGICAL:** Autologous Mesenchymal Stem Cells
- **BIOLOGICAL:** Autologous Mesenchymal Stem Cells
- **BIOLOGICAL:** Autologous Mesenchymal Stem Cells

## Key facts

- **NCT ID:** NCT02315027
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2012-10
- **Primary completion:** 2027-03
- **Final completion:** 2027-03
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2026-04-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02315027

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02315027, "Mesenchymal Stem Cell Therapy in Multiple System Atrophy". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT02315027. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*